
16 Mar 2021
4basebio - Next generation DNA synthesis and delivery technology
4basebio is focused on the manufacture and supply of synthetic DNA for gene therapies and DNA vaccines, and on providing solutions for effective delivery of these products to patients. Its proprietary next generation technology, including hpDNA™, Hermes™ nanoparticles and TruePrime©, has the potential to address industry-wide bottlenecks and key challenges in the burgeoning cell and gene therapy market. The company aims to develop a CRO/CMO style business, manufacturing synthetic DNA and develop ....

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
4basebio - Next generation DNA synthesis and delivery technology
4basebio PLC (4BB:LON) | 1,125 0 0.0% | Mkt Cap: 174.3m
- Published:
16 Mar 2021 -
Author:
Mark Brewer | Cavendish Research -
Pages:
26 -
4basebio is focused on the manufacture and supply of synthetic DNA for gene therapies and DNA vaccines, and on providing solutions for effective delivery of these products to patients. Its proprietary next generation technology, including hpDNA™, Hermes™ nanoparticles and TruePrime©, has the potential to address industry-wide bottlenecks and key challenges in the burgeoning cell and gene therapy market. The company aims to develop a CRO/CMO style business, manufacturing synthetic DNA and develop ....